NTRP
NASDAQ
$1.90
Neurotrope Inc (NTRP)
Neurotrope, Inc., a biopharmaceutical company, is focused on developing a product platform for the treatment of Alzheimer's disease. The company is headquartered in New York, New York.
Sector:
Consumer Cyclical
Industry:
Travel Services
Buy
Target: $6.83 (+259.47%)
Market Cap
$29M
Revenue 5Y CAGR
+20.34%
Free Cash Flow Yield
-16.00%
Beta (5Y)
0.48
Price Chart
Valuation
Market Cap$29M
P/S7.99
P/B5.07
Profitability
Total Revenue (TTM)$3.72M
Gross Profit (TTM)$822K
EBITDA-$15M
Operating Margin-307.2%
EPS-$1.58
Financial Health
Free Cash Flow Yield-16.00%
Growth & Risk
EPS 5Y CAGR+17.78%
Revenue 5Y CAGR+20.34%
FCF 5Y CAGR-5.45%
Beta (5Y)0.48
Sharpe Ratio-0.33